These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 32028527)

  • 1. HPF1 completes the PARP active site for DNA damage-induced ADP-ribosylation.
    Suskiewicz MJ; Zobel F; Ogden TEH; Fontana P; Ariza A; Yang JC; Zhu K; Bracken L; Hawthorne WJ; Ahel D; Neuhaus D; Ahel I
    Nature; 2020 Mar; 579(7800):598-602. PubMed ID: 32028527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bridging of DNA breaks activates PARP2-HPF1 to modify chromatin.
    Bilokapic S; Suskiewicz MJ; Ahel I; Halic M
    Nature; 2020 Sep; 585(7826):609-613. PubMed ID: 32939087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serine-linked PARP1 auto-modification controls PARP inhibitor response.
    Prokhorova E; Zobel F; Smith R; Zentout S; Gibbs-Seymour I; Schützenhofer K; Peters A; Groslambert J; Zorzini V; Agnew T; Brognard J; Nielsen ML; Ahel D; Huet S; Suskiewicz MJ; Ahel I
    Nat Commun; 2021 Jul; 12(1):4055. PubMed ID: 34210965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPF1 remodels the active site of PARP1 to enable the serine ADP-ribosylation of histones.
    Sun FH; Zhao P; Zhang N; Kong LL; Wong CCL; Yun CH
    Nat Commun; 2021 Feb; 12(1):1028. PubMed ID: 33589610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPF1 dynamically controls the PARP1/2 balance between initiating and elongating ADP-ribose modifications.
    Langelier MF; Billur R; Sverzhinsky A; Black BE; Pascal JM
    Nat Commun; 2021 Nov; 12(1):6675. PubMed ID: 34795260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Poly(ADP-Ribose) Polymerases 1 and 2: Classical Functions and Interaction with New Histone Poly(ADP-Ribosyl)ation Factor HPF1].
    Kurgina TA; Lavrik OI
    Mol Biol (Mosk); 2023; 57(2):254-268. PubMed ID: 37000654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual function of HPF1 in the modulation of PARP1 and PARP2 activities.
    Kurgina TA; Moor NA; Kutuzov MM; Naumenko KN; Ukraintsev AA; Lavrik OI
    Commun Biol; 2021 Nov; 4(1):1259. PubMed ID: 34732825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PARP Power: A Structural Perspective on PARP1, PARP2, and PARP3 in DNA Damage Repair and Nucleosome Remodelling.
    van Beek L; McClay É; Patel S; Schimpl M; Spagnolo L; Maia de Oliveira T
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34066057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PARP1/2 and Accessory Factor HPF1 Interlock to Form a Joint Active Site.
    Cancer Discov; 2020 Apr; 10(4):486. PubMed ID: 32060056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPF1/C4orf27 Is a PARP-1-Interacting Protein that Regulates PARP-1 ADP-Ribosylation Activity.
    Gibbs-Seymour I; Fontana P; Rack JGM; Ahel I
    Mol Cell; 2016 May; 62(3):432-442. PubMed ID: 27067600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPF1-dependent histone ADP-ribosylation triggers chromatin relaxation to promote the recruitment of repair factors at sites of DNA damage.
    Smith R; Zentout S; Rother M; Bigot N; Chapuis C; Mihuț A; Zobel FF; Ahel I; van Attikum H; Timinszky G; Huet S
    Nat Struct Mol Biol; 2023 May; 30(5):678-691. PubMed ID: 37106138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of PARP2/ARTD2 by DNA damage induces conformational changes relieving enzyme autoinhibition.
    Obaji E; Maksimainen MM; Galera-Prat A; Lehtiö L
    Nat Commun; 2021 Jun; 12(1):3479. PubMed ID: 34108479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput screening assay for PARP-HPF1 interaction inhibitors to affect DNA damage repair.
    Dhakar SS; Galera-Prat A; Lehtiö L
    Sci Rep; 2024 Feb; 14(1):3875. PubMed ID: 38365924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serine ADP-ribosylation reversal by the hydrolase ARH3.
    Fontana P; Bonfiglio JJ; Palazzo L; Bartlett E; Matic I; Ahel I
    Elife; 2017 Jun; 6():. PubMed ID: 28650317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPF1 and nucleosomes mediate a dramatic switch in activity of PARP1 from polymerase to hydrolase.
    Rudolph J; Roberts G; Muthurajan UM; Luger K
    Elife; 2021 Mar; 10():. PubMed ID: 33683197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serine ADP-Ribosylation Depends on HPF1.
    Bonfiglio JJ; Fontana P; Zhang Q; Colby T; Gibbs-Seymour I; Atanassov I; Bartlett E; Zaja R; Ahel I; Matic I
    Mol Cell; 2017 Mar; 65(5):932-940.e6. PubMed ID: 28190768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone Parylation factor 1 contributes to the inhibition of PARP1 by cancer drugs.
    Rudolph J; Roberts G; Luger K
    Nat Commun; 2021 Feb; 12(1):736. PubMed ID: 33531508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The HPF1-dependent histone PARylation catalyzed by PARP2 is specifically stimulated by an incised AP site-containing BER DNA intermediate.
    Kurgina TA; Moor NA; Kutuzov MM; Lavrik OI
    DNA Repair (Amst); 2022 Dec; 120():103423. PubMed ID: 36356486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dynamics and regulation of PARP1 and PARP2 in response to DNA damage and during replication.
    Zhang H; Zha S
    DNA Repair (Amst); 2024 Aug; 140():103690. PubMed ID: 38823186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress and outlook in studying the substrate specificities of PARPs and related enzymes.
    Suskiewicz MJ; Palazzo L; Hughes R; Ahel I
    FEBS J; 2021 Apr; 288(7):2131-2142. PubMed ID: 32785980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.